Jim Cramer Calls Big Tech ‘Millstones' and Names the ‘New Techs' Taking Over
Jim Cramer identified companies supplying drug labs and research instruments as potential successors to the data-center trade, noting that three stocks have outperformed the NASDAQ-100 this year.
Why it matters — Agilent supplies research instruments, so the item’s focus on that industry may be relevant to A watchers, though the excerpt does not name Agilent.